7-92615316-TATACA-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001145306.2(CDK6):c.835-35_835-31delTGTAT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,525,002 control chromosomes in the GnomAD database, including 38,355 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.18 ( 2993 hom., cov: 27)
Exomes 𝑓: 0.22 ( 35362 hom. )
Consequence
CDK6
NM_001145306.2 intron
NM_001145306.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.862
Publications
0 publications found
Genes affected
CDK6 (HGNC:1777): (cyclin dependent kinase 6) The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]
CDK6 Gene-Disease associations (from GenCC):
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- microcephaly 12, primary, autosomal recessiveInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 7-92615316-TATACA-T is Benign according to our data. Variant chr7-92615316-TATACA-T is described in ClinVar as [Benign]. Clinvar id is 1252462.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK6 | NM_001145306.2 | c.835-35_835-31delTGTAT | intron_variant | Intron 7 of 7 | ENST00000424848.3 | NP_001138778.1 | ||
CDK6 | NM_001259.8 | c.835-35_835-31delTGTAT | intron_variant | Intron 7 of 7 | NP_001250.1 | |||
CDK6 | XM_047419716.1 | c.835-35_835-31delTGTAT | intron_variant | Intron 7 of 7 | XP_047275672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK6 | ENST00000424848.3 | c.835-35_835-31delTGTAT | intron_variant | Intron 7 of 7 | 1 | NM_001145306.2 | ENSP00000397087.3 | |||
CDK6 | ENST00000265734.8 | c.835-35_835-31delTGTAT | intron_variant | Intron 7 of 7 | 1 | ENSP00000265734.4 | ||||
CDK6 | ENST00000467166.1 | n.207-35_207-31delTGTAT | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes AF: 0.180 AC: 27294AN: 151956Hom.: 2999 Cov.: 27 show subpopulations
GnomAD3 genomes
AF:
AC:
27294
AN:
151956
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.183 AC: 44981AN: 245744 AF XY: 0.186 show subpopulations
GnomAD2 exomes
AF:
AC:
44981
AN:
245744
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.217 AC: 298570AN: 1372928Hom.: 35362 AF XY: 0.215 AC XY: 148047AN XY: 688234 show subpopulations
GnomAD4 exome
AF:
AC:
298570
AN:
1372928
Hom.:
AF XY:
AC XY:
148047
AN XY:
688234
show subpopulations
African (AFR)
AF:
AC:
1995
AN:
31744
American (AMR)
AF:
AC:
5786
AN:
44458
Ashkenazi Jewish (ASJ)
AF:
AC:
7133
AN:
25504
East Asian (EAS)
AF:
AC:
619
AN:
39306
South Asian (SAS)
AF:
AC:
9669
AN:
84508
European-Finnish (FIN)
AF:
AC:
12312
AN:
53216
Middle Eastern (MID)
AF:
AC:
982
AN:
5004
European-Non Finnish (NFE)
AF:
AC:
247891
AN:
1031864
Other (OTH)
AF:
AC:
12183
AN:
57324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
10913
21826
32738
43651
54564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.179 AC: 27285AN: 152074Hom.: 2993 Cov.: 27 AF XY: 0.177 AC XY: 13187AN XY: 74354 show subpopulations
GnomAD4 genome
AF:
AC:
27285
AN:
152074
Hom.:
Cov.:
27
AF XY:
AC XY:
13187
AN XY:
74354
show subpopulations
African (AFR)
AF:
AC:
2994
AN:
41520
American (AMR)
AF:
AC:
2523
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
986
AN:
3466
East Asian (EAS)
AF:
AC:
85
AN:
5188
South Asian (SAS)
AF:
AC:
501
AN:
4820
European-Finnish (FIN)
AF:
AC:
2346
AN:
10554
Middle Eastern (MID)
AF:
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17033
AN:
67922
Other (OTH)
AF:
AC:
442
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1093
2186
3279
4372
5465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
282
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.